VOLUVEN Side Effects

6761716-5 | Clostridial Infection, Myocardial Depression, Respiratory Failure, Septic Shock, Toxic Epidermal Necrolysis
on Dec 12, 2009 Male patient from GERMANY , 69 years of age, was diagnosed with sepsis (What is sepsis?) and was treated with Voluven (View Usage). Patient experienced the following unwanted or unexpected effects: clostridial infection, myocardial depression, respiratory failure, septic shock, toxic epidermal necrolysis. Voluven dosage: (500 Ml) Intravenous Drip. During the same period patient was treated with CIPROFLOXACIN (View Ciprofloxacin Review and Ciprofloxacin Label ), VANCOMYCIN (View Vancomycin Review and Vancomycin Label ), METRONIDAZOLE (View Metronidazole Review and Metronidazole Label ), TOBRAMYCINE (TOBRAMYCIN SULFATE) (TOBRAMYCIN SULFATE) (View Tobramycine (tobramycin Sulfate) (tobramycin Sulfate) Review and Tobramycine (tobramycin Sulfate) (tobramycin Sulfate) Label ), MEROPENEM (MEROPENEM) (MEROPENEM) (View Meropenem (meropenem) (meropenem) Review and Meropenem (meropenem) (meropenem) Label ), FFPS (BLOODPLASMA) (BLOODPLASMA) (View Ffps (bloodplasma) (bloodplasma) Review and Ffps (bloodplasma) (bloodplasma) Label ), PRBCS (RED BLOOD CELLS) (RED BLOOD CELLS) (View Prbcs (red Blood Cells) (red Blood Cells) Review and Prbcs (red Blood Cells) (red Blood Cells) Label ), CLOTTING FACTOR XIII (FACTOR XIII (FIBRIN STABILISING FACTOR)) (FACTOR (View Clotting Factor Xiii (factor Xiii (fibrin Stabilising Factor)) (factor Review and Clotting Factor Xiii (factor Xiii (fibrin Stabilising Factor)) (factor Label ).

6720424-7 | Adrenal Haemorrhage, Cardiac Failure, Cholestasis, Clostridial Infection, Hepatic Necrosis, Inflammation, Myocardial Depression, Oesophageal Stenosis, Pleurisy
Patient was taking Voluven (View Usage). Patient had the following side effects: adrenal haemorrhage, cardiac failure, cholestasis, clostridial infection, hepatic necrosis, inflammation, myocardial depression, oesophageal stenosis, pleurisy on Dec 12, 2009 from GERMANY Additional patient health information: Male patient , 69 years of age, was diagnosed with sepsis (What is sepsis?) and. Voluven dosage: (500 Ml), Intravenous Drip. During the same period patient was treated with CIPROFLOXACIN (View Ciprofloxacin Review and Ciprofloxacin Label ), VANCOMYCIN (View Vancomycin Review and Vancomycin Label ), METRONIDAZOLE (View Metronidazole Review and Metronidazole Label ), TOBRAMYCINE (TOBRAMYCIN SULFATE) (TOBRAMYCIN SULFATE) (View Tobramycine (tobramycin Sulfate) (tobramycin Sulfate) Review and Tobramycine (tobramycin Sulfate) (tobramycin Sulfate) Label ), MEROPENEM (MEROPENEM) (MEROPENEM) (View Meropenem (meropenem) (meropenem) Review and Meropenem (meropenem) (meropenem) Label ), FFPS (BLOODPLASMA) (BLOODPLASMA) (View Ffps (bloodplasma) (bloodplasma) Review and Ffps (bloodplasma) (bloodplasma) Label ), PRBCS (RED BLOOD CELLS) (RED BLOOD CELLS) (View Prbcs (red Blood Cells) (red Blood Cells) Review and Prbcs (red Blood Cells) (red Blood Cells) Label ), CLOTTING FACTOR XIII (FACTOR XIII (FIBRIN STABILISING FACTOR)) (FACTOR (View Clotting Factor Xiii (factor Xiii (fibrin Stabilising Factor)) (factor Review and Clotting Factor Xiii (factor Xiii (fibrin Stabilising Factor)) (factor Label ).

6565883-8 | Hyperkalaemia, Tachyarrhythmia
Adverse event was reported on Dec 03, 2009 by a Female patient taking Voluven (View Usage) (Dosage: 500 Ml (500 Ml), Intravenous Bolus) was diagnosed with surgery (What is surgery?) and. Location: CZECH REPUBLIC , 17 years of age, After Voluven was administered, patient had the following side effects: hyperkalaemia, tachyarrhythmia.

6548981-4 | Anaphylactic Reaction, Arrhythmia
on Dec 15, 2009 Female patient from MEXICO , 35 years of age, was diagnosed with surgery (What is surgery?) and was treated with Voluven (View Usage). Patient experienced the following unwanted or unexpected effects: anaphylactic reaction, arrhythmia (What is arrhythmia?). Voluven dosage: Intravenous. During the same period patient was treated with FENTANYL (View Fentanyl Review and Fentanyl Label ), BUPIVACAINE (BUPIVACAINE) (BUPIVACAINE) (View Bupivacaine (bupivacaine) (bupivacaine) Review and Bupivacaine (bupivacaine) (bupivacaine) Label ), METRONIDAZOLE (View Metronidazole Review and Metronidazole Label ), GENTAMICIN (View Gentamicin Review and Gentamicin Label ), CEFOTAXIME (CEFOTAXIME) (CEFOTAXIME) (View Cefotaxime (cefotaxime) (cefotaxime) Review and Cefotaxime (cefotaxime) (cefotaxime) Label ), AMICAKIN (AMIKACIN SULFATE) (AMIKACIN SULFATE) (View Amicakin (amikacin Sulfate) (amikacin Sulfate) Review and Amicakin (amikacin Sulfate) (amikacin Sulfate) Label ), METAMIZOLE (METAMIZOLE) (METAMIZOLE) (View Metamizole (metamizole) (metamizole) Review and Metamizole (metamizole) (metamizole) Label ), RANITIDINE (RANITIDINE) (RANITIDINE) (View Ranitidine (ranitidine) (ranitidine) Review and Ranitidine (ranitidine) (ranitidine) Label ). Patient was hospitalized.


6454780-4 | Arrhythmia, Blood Potassium Increased, Crime
on Nov 11, 2009 Female patient from CZECH REPUBLIC , 17 years of age, was diagnosed with surgery (What is surgery?) and was treated with Voluven (View Usage). Patient had the following side effects: arrhythmia (What is arrhythmia?), blood potassium increased, crime. Voluven dosage: 500 Ml, Intravenous Bolus.

6173878-1 | Cardiac Arrest, Ventricular Tachycardia
Patient was taking Voluven (View Usage). After Voluven was administered, patient had the following side effects: cardiac arrest (What is cardiac arrest?), ventricular tachycardia on Feb 14, 2009 from Additional patient health information: Male patient , 57 years of age, was diagnosed with hypovolaemia and. Voluven dosage: 500 Ml. During the same period patient was treated with ATROPINE (ATROPINE) (ATROPINE) (View Atropine (atropine) (atropine) Review and Atropine (atropine) (atropine) Label ), DIPRIVAN (View Diprivan Review and Diprivan Label ), ULTIVA (REMIFENTANIL HYDROCHLORIDE) (FEMIFENTANIL HYDROCHLORIDE) (View Ultiva (remifentanil Hydrochloride) (femifentanil Hydrochloride) Review and Ultiva (remifentanil Hydrochloride) (femifentanil Hydrochloride) Label ), NIMBEX (CISATRACURIUM BESILATE) (CISATRACURIUM BESILATE) (View Nimbex (cisatracurium Besilate) (cisatracurium Besilate) Review and Nimbex (cisatracurium Besilate) (cisatracurium Besilate) Label ).

6173877-X | Nephrotic Syndrome, Renal Failure Acute, Renal Failure Chronic
Adverse event was reported on Feb 22, 2009 by a Male patient taking Voluven (View Usage) (Dosage: ) was diagnosed with septic shock and. Location: , 69 years of age, Patient experienced the following unwanted or unexpected effects: nephrotic syndrome, renal failure acute, renal failure chronic. During the same period patient was treated with SOCIUM CHLORIDE (SODIUM CHLORIDE) (View Socium Chloride (sodium Chloride) Review and Socium Chloride (sodium Chloride) Label ), AMOXICILLING.CLAVULANIC ACID (AMOXI CLAVULANICO) (AMOXI CLAVULANICO) (View Amoxicilling.clavulanic Acid (amoxi-clavulanico) (amoxi-clavulanico) Review and Amoxicilling.clavulanic Acid (amoxi-clavulanico) (amoxi-clavulanico) Label ), CLARITHROMYCIN (View Clarithromycin Review and Clarithromycin Label ), MEROPENEM (MEROPENEM) (MEROPENEM) (View Meropenem (meropenem) (meropenem) Review and Meropenem (meropenem) (meropenem) Label ).

6173874-4 | Vasoplegia Syndrome
on Mar 17, 2009 Male patient from , 63 years of age, was diagnosed with vascular graft and was treated with Voluven (View Usage). Patient had the following side effects: vasoplegia syndrome. Voluven dosage: Intravenous (not Otherwis. During the same period patient was treated with NIMBEX (CISATRACURIUM BESILATE) (CISATRACURIUM BESILATE) (View Nimbex (cisatracurium Besilate) (cisatracurium Besilate) Review and Nimbex (cisatracurium Besilate) (cisatracurium Besilate) Label ).

6173874-4 | Vasoplegia Syndrome
on Mar 17, 2009 Male patient from FRANCE , 63 years of age, was diagnosed with vascular graft and was treated with Voluven (View Usage). After Voluven was administered, patient had the following side effects: vasoplegia syndrome. Voluven dosage: Intravenous (not Otherwis. During the same period patient was treated with PROPOFOL (Intravenous (not Otherwise Specified)) (View Propofol Review and Propofol Label ), NIMBEX (View Nimbex Review and Nimbex Label ).

6062357-8 | Acute Respiratory Distress Syndrome, Fluid Overload, Respiratory Disorder
Patient was taking Voluven (View Usage). Patient experienced the following unwanted or unexpected effects: acute respiratory distress syndrome, fluid overload, respiratory disorder on Feb 02, 2009 from CANADA Additional patient health information: Male patient , 39 years of age, weighting 176.4 lb, was diagnosed with fluid replacement and. Voluven dosage: Intravenous. During the same period patient was treated with ISOFLURANE (View Isoflurane Review and Isoflurane Label ), PROPOFOL (View Propofol Review and Propofol Label ), ROCURONIUM BROMIDE (View Rocuronium Bromide Review and Rocuronium Bromide Label ).

5811216-1 | Anaphylactic Shock, Bronchospasm, Hypotension, Rash
Adverse event was reported on Jul 04, 2008 by a Female patient taking Voluven (View Usage) (Dosage: 200 Ml, Intravenous Drip) was diagnosed with hypovolaemia and. Location: ITALY , 56 years of age, Patient had the following side effects: anaphylactic shock, bronchospasm, hypotension, rash (What is rash?).

5673345-5 | Angioedema
on Mar 06, 2008 Male patient from INDIA , 72 years of age, weighting 154.3 lb, was diagnosed with operative haemorrhage and was treated with Voluven (View Usage). After Voluven was administered, patient had the following side effects: angioedema. Voluven dosage: 200 Ml, Intravenous Drip.

5635848-9 | Hypersensitivity
on Feb 14, 2008 Male patient from GERMANY , 15 years of age, was diagnosed with surgery (What is surgery?) and was treated with Voluven (View Usage). Patient experienced the following unwanted or unexpected effects: hypersensitivity. Voluven dosage: .